Global Blood Screening Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
MarketResearch.biz delivers in-depth insights on the global blood screening market in its upcoming report titled, “Global Blood Screening Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2027”. The global blood screening market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global blood screening blood screening market report has been segmented on the basis of technology, product, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Blood screening is a process in which different tests are carried out on donated blood samples for diagnosing several infectious diseases such as hepatitis, HIV and AIDS, and other tests. All tests performed on blood sample are recorded according to standardized procedures in laboratories. Test results helps to monitor various diseases, health issues, and other clinical conditions such as cancer and infections.
Increasing number of blood donations, increasing incidence/prevalence of infectious diseases, and government initiatives for increasing awareness regarding the safety of blood donation are major factors expected to driving growth of the global market over the forecast period. In addition, rising affordability and increasing adoption of nucleic acid amplification test (NAT) for blood screening, rising demand for donated blood are other factors expected to further fuel growth of the target market in the near future. Furthermore, technological advancements and increasing awareness about transfusion-transmitted diseases are other factors expected to propel growth of this market during the forecast period.
However, availability of alternative technologies such as digital immunoassay, lack of skilled people are major factors expected to restrain growth of the global market over the forecast period. In addition, strict regulatory scenario for approval is another factor expected to hamper growth of the target market in the near future.
Increasing technological advancements and introduction of new technologies such as pathogen reduction technology and microbiology screening and multiplexing are expected to create potential revenue opportunities for players operating in the target market over the forecast period.
The market in North America is expected to dominate the target market in terms of revenue over the forecast period, owing to rising adoption of nucleic acid tests (NAT) and increasing initiatives by various organizations and government associations in blood donations and screening & transfusion activities in various countries in the region. The market in Asia Pacific is expected to register significant share in terms of revenue over the forecast period, owing to increasing demand for donated blood, improved healthcare infrastructure, and increasing government funding’s in various countries in the region.
Global blood screening market segmentation:
Segmentation by technology:
- Nucleic Acid Amplification Test (NAT)
- Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
- Next-Generation Sequencing (NGS)
- Western Blotting
Segmentation by product:
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- Ortho-Clinical Diagnostics, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Hoffmann-La Roche Ltd.
- Siemens Healthcare GmbH
- Beckman Coulter, Inc.
- Roche Diagnostics Corporation
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!